Adrian is an investor-operator with more than 20 years of experience in the healthcare sector, specialising in medtech, biotech and the life sciences tools space. He brings 10 years of experience developing FDA-approved medical devices, leading R&D teams and scaling healthcare ventures, and over 10 years of equity research and portfolio management in private and public equity markets. Adrian is currently CEO of an AI-enabled cardiovascular digital health company CorVista Health. Adrian also serves as Partner in Bioworld Ventures, Venture Partner for Verge Healthtech Fund and Vectr Ventures, and he’s part of the Hong Kong Science and Technology Parks’ Incu-Bio and the Hong Kong Government's Innovation and Technology Fund Assessment Panels. Adrian is a CFA Charterholder, and he previously was director for business development and venture capital at Genesis Medtech Group and a portfolio manager at Sectoral Asset Management, a global healthcare specialist investment firm. Prior to that, he led an R&D group at Stryker Corporation, a Fortune 500 company.